Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 19 studies | 35% ± 17% | |
endothelial cell | 16 studies | 23% ± 7% | |
pericyte | 15 studies | 25% ± 8% | |
smooth muscle cell | 12 studies | 21% ± 5% | |
fibroblast | 11 studies | 25% ± 8% | |
capillary endothelial cell | 6 studies | 20% ± 4% | |
retina horizontal cell | 6 studies | 65% ± 17% | |
basal cell | 5 studies | 24% ± 4% | |
adipocyte | 5 studies | 28% ± 1% | |
Mueller cell | 5 studies | 49% ± 20% | |
endothelial cell of vascular tree | 5 studies | 23% ± 1% | |
epithelial cell | 4 studies | 34% ± 13% | |
myofibroblast cell | 4 studies | 29% ± 11% | |
secretory cell | 4 studies | 19% ± 3% | |
glomerular endothelial cell | 3 studies | 33% ± 5% | |
ciliated cell | 3 studies | 24% ± 7% | |
abnormal cell | 3 studies | 17% ± 1% | |
connective tissue cell | 3 studies | 26% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 9038.01 | 180 / 180 | 100% | 132.53 | 430 / 430 |
pancreas | 100% | 5103.53 | 328 / 328 | 100% | 62.05 | 178 / 178 |
esophagus | 100% | 4835.91 | 1444 / 1445 | 99% | 79.52 | 182 / 183 |
brain | 100% | 7034.22 | 2632 / 2642 | 100% | 191.71 | 703 / 705 |
uterus | 100% | 8232.04 | 170 / 170 | 99% | 93.62 | 453 / 459 |
intestine | 100% | 6631.64 | 966 / 966 | 98% | 53.53 | 519 / 527 |
breast | 100% | 11470.82 | 459 / 459 | 98% | 84.66 | 1098 / 1118 |
thymus | 100% | 7370.36 | 652 / 653 | 98% | 67.58 | 594 / 605 |
prostate | 100% | 6023.54 | 245 / 245 | 97% | 48.05 | 489 / 502 |
stomach | 100% | 5041.91 | 359 / 359 | 97% | 57.36 | 276 / 286 |
lung | 100% | 5834.52 | 577 / 578 | 97% | 61.11 | 1115 / 1155 |
bladder | 100% | 5120.10 | 21 / 21 | 94% | 55.14 | 475 / 504 |
adrenal gland | 100% | 7603.50 | 258 / 258 | 90% | 91.03 | 207 / 230 |
liver | 98% | 2373.92 | 222 / 226 | 91% | 39.87 | 368 / 406 |
kidney | 100% | 3650.52 | 89 / 89 | 86% | 39.44 | 778 / 901 |
skin | 100% | 5363.28 | 1805 / 1809 | 76% | 37.93 | 360 / 472 |
adipose | 100% | 11935.65 | 1204 / 1204 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 18.56 | 1 / 1 |
blood vessel | 100% | 4424.40 | 1332 / 1335 | 0% | 0 | 0 / 0 |
spleen | 99% | 3551.77 | 239 / 241 | 0% | 0 | 0 / 0 |
heart | 99% | 3928.90 | 852 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 178.64 | 44 / 45 |
eye | 0% | 0 | 0 / 0 | 98% | 49.96 | 78 / 80 |
muscle | 84% | 2313.50 | 671 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 21% | 5.01 | 6 / 29 |
peripheral blood | 8% | 129.28 | 72 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007266 | Biological process | Rho protein signal transduction |
GO_0008360 | Biological process | regulation of cell shape |
GO_0030838 | Biological process | positive regulation of actin filament polymerization |
GO_0031274 | Biological process | positive regulation of pseudopodium assembly |
GO_0071346 | Biological process | cellular response to type II interferon |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005829 | Cellular component | cytosol |
GO_0005912 | Cellular component | adherens junction |
GO_0015630 | Cellular component | microtubule cytoskeleton |
GO_0045335 | Cellular component | phagocytic vesicle |
GO_0005886 | Cellular component | plasma membrane |
GO_0012505 | Cellular component | endomembrane system |
GO_0005737 | Cellular component | cytoplasm |
GO_0005515 | Molecular function | protein binding |
GO_0031267 | Molecular function | small GTPase binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | CDC42EP4 |
Protein name | CDC42 effector protein 4 Cdc42 effector protein 4 (Binder of Rho GTPases 4) CDC42 effector protein (Rho GTPase binding) 4, isoform CRA_a (cDNA FLJ14479 fis, clone MAMMA1002143, highly similar to Cdc42 effector protein 4 (Binder of Rho GTPases 4)) (cDNA, FLJ92905, Homo sapiens CDC42 effector protein (Rho GTPase binding) 4(CDC42EP4), mRNA) |
Synonyms | hCG_27835 CEP4 BORG4 |
Description | FUNCTION: Probably involved in the organization of the actin cytoskeleton. May act downstream of CDC42 to induce actin filament assembly leading to cell shape changes. Induces pseudopodia formation, when overexpressed in fibroblasts. |
Accessions | ENST00000580315.1 ENST00000630622.1 ENST00000579611.1 J3QQS6 ENST00000439510.2 [Q9H3Q1-2] J3QR93 Q9H3Q1 ENST00000335793.4 [Q9H3Q1-1] ENST00000581014.1 J3KRZ9 B2R6D8 |